Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
12
2019
accepted:
11
06
2020
entrez:
3
7
2020
pubmed:
3
7
2020
medline:
10
9
2020
Statut:
epublish
Résumé
Tuberculosis (TB) is the leading cause of death among people living with HIV (PLWH), and current evidence suggests that heavy alcohol users have an increased risk of developing TB disease compared to non-drinkers. Not known is whether the increased risk for TB disease among alcohol users may reflect higher rates of latent TB infection (LTBI) among this population. We assessed the latent TB infection prevalence based on tuberculin skin testing (TST) and examined association with current alcohol use among HIV-infected persons on antiretroviral therapy (ART) in south-western Uganda. We included PLWH at the Mbarara Regional Hospital HIV clinic, who were either current alcohol consumers (prior 3 months) or past year abstainers (2:1 enrolment ratio). Participants were recruited for a study of isoniazid preventive therapy for LTBI. TST was performed using 5 tuberculin units of purified protein derivative. The primary outcome was a positive TST reading (≥5mm induration), reflecting LTBI. We used logistic regression analyses to assess the cross-sectional association between self-reported current alcohol use and a positive TST. Of the 295 of 312 (95%) who returned for TST reading, 63% were females and 63% were current alcohol drinkers. The TST positive prevalence was 27.5% (95% confidence interval [CI]: 22.6% - 32.9%). The odds of a positive TST for current alcohol users compared to abstainers was 0.76 (95% CI: 0.41, 1.41), controlling for gender, age, body mass index, history of smoking, and prior unhealthy alcohol use. The prevalence of LTBI among PLWH on ART in south-western Uganda was moderate and LTBI poses a risk for future infectious TB. Although alcohol use is common, we did not detect an association between current drinking or prior unhealthy alcohol use and LTBI. Further studies to evaluate the association between LTBI and different levels of current drinking (heavy versus not) are needed.
Sections du résumé
BACKGROUND
Tuberculosis (TB) is the leading cause of death among people living with HIV (PLWH), and current evidence suggests that heavy alcohol users have an increased risk of developing TB disease compared to non-drinkers. Not known is whether the increased risk for TB disease among alcohol users may reflect higher rates of latent TB infection (LTBI) among this population. We assessed the latent TB infection prevalence based on tuberculin skin testing (TST) and examined association with current alcohol use among HIV-infected persons on antiretroviral therapy (ART) in south-western Uganda.
METHODS
We included PLWH at the Mbarara Regional Hospital HIV clinic, who were either current alcohol consumers (prior 3 months) or past year abstainers (2:1 enrolment ratio). Participants were recruited for a study of isoniazid preventive therapy for LTBI. TST was performed using 5 tuberculin units of purified protein derivative. The primary outcome was a positive TST reading (≥5mm induration), reflecting LTBI. We used logistic regression analyses to assess the cross-sectional association between self-reported current alcohol use and a positive TST.
RESULTS
Of the 295 of 312 (95%) who returned for TST reading, 63% were females and 63% were current alcohol drinkers. The TST positive prevalence was 27.5% (95% confidence interval [CI]: 22.6% - 32.9%). The odds of a positive TST for current alcohol users compared to abstainers was 0.76 (95% CI: 0.41, 1.41), controlling for gender, age, body mass index, history of smoking, and prior unhealthy alcohol use.
CONCLUSIONS
The prevalence of LTBI among PLWH on ART in south-western Uganda was moderate and LTBI poses a risk for future infectious TB. Although alcohol use is common, we did not detect an association between current drinking or prior unhealthy alcohol use and LTBI. Further studies to evaluate the association between LTBI and different levels of current drinking (heavy versus not) are needed.
Identifiants
pubmed: 32614873
doi: 10.1371/journal.pone.0235261
pii: PONE-D-19-35988
pmc: PMC7332058
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0235261Subventions
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020776
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24 AA022586
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020779
Pays : United States
Déclaration de conflit d'intérêts
Author DC serves on Data Safety and Monitoring Board for Janssen. The other authors have no conflicts of interest to declare. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Addiction. 2016 Feb;111(2):272-9
pubmed: 26381193
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
N Engl J Med. 1995 Jul 27;333(4):222-7
pubmed: 7791838
BMC Public Health. 2009 Dec 05;9:450
pubmed: 19961618
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):492-501
pubmed: 29303844
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
BMC Infect Dis. 2015 Mar 29;15:165
pubmed: 25879423
BMC Infect Dis. 2011 Apr 09;11:89
pubmed: 21477326
Curr Opin Pulm Med. 2009 May;15(3):188-200
pubmed: 19387262
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Scand J Infect Dis. 2003;35(11-12):863-8
pubmed: 14723363
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
AIDS Care. 2014;26(10):1288-97
pubmed: 24773163
PLoS One. 2015 Nov 09;10(11):e0142290
pubmed: 26551023
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171
pubmed: 20091503
AIDS Behav. 2016 Oct;20(10):2408-2417
pubmed: 27150894
Ann Intern Med. 2008 Aug 5;149(3):177-84
pubmed: 18593687
PLoS One. 2015 Oct 27;10(10):e0141511
pubmed: 26505997
Eur Respir J. 2017 Jul 13;50(1):
pubmed: 28705945
AIDS Behav. 2014 Mar;18(3):525-34
pubmed: 23921585
BMC Infect Dis. 2016 Nov 8;16(1):661
pubmed: 27825307
N Engl J Med. 2015 Aug 27;373(9):808-22
pubmed: 26193126
PLoS One. 2015 May 11;10(5):e0126236
pubmed: 25962171
Front Biosci. 2002 May 01;7:d1314-30
pubmed: 11991862
PLoS One. 2011 Apr 04;6(4):e18206
pubmed: 21483746
Addiction. 2010 May;105(5):817-43
pubmed: 20331573
Trans R Soc Trop Med Hyg. 2017 Feb 1;111(2):55-61
pubmed: 28407146